Shopping Cart 0
Cart Subtotal

Contraceptive Market by Method Type (Contraceptive Pills, Injectables, Female Sterilization, Intrauterine Devices & Systems, Male Condom, Emergency Contraception and Other) - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4199

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6299

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 8399
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase


The report covers forecast and analysis for the contraceptive market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the contraceptive market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the contraceptive market on a global level. This report offers comprehensive coverage on the global contraceptive market along with, market trends, drivers, and restraints of contraceptive market. This report includes a detailed competitive scenario and technology portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the contraceptive market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report. The study provides a decisive view on the contraceptive market by segmenting the market based on method type and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The method type market covered under this study includes contraceptive pills, injectables, female sterilization, intrauterine devices systems, male condom, emergency contraception and other. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific, Latin America and the Middle East Africa. Key operating players in contraceptive market are like The Female Health Company, Teva Pharmaceutical Industries, Bayer Healthcare Pharmaceuticals, Piramal Healthcare Limited, Reckitt Benckiser Plc., Cipla Limited, Novartis AG, Lupin Pharmaceuticals, Inc, Pfizer, Inc., Amgen Inc., Sun Pharmaceutical Industries Ltd., and Glenmark Pharmaceuticals. This report segments the contraceptive market as follows: Contraceptive Market: Method Type Analysis Contraceptive Pill Injectable Female Sterilization Intrauterine devices and systems Male Condom Emergency contraception Other Contraceptive Market: Regional Type Analysis North America Europe Asia Pacific Latin America The Middle East and Africa


Table Of Content


Chapter 1. Introduction 1.1. Report Description And Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter 2. Executive Summary 2.1. Global Contraceptive market, 2015-2021 (USD Billion) 2.2. Global Contraceptive market: Snapshot Chapter 3. Contraceptive Market Market Dynamics 3.1. Introduction 3.2. Market Drivers 3.2.1. Global Contraceptive market drivers: Impact Analysis 3.2.2. Increasing prevalence of sexually transmitted infections 3.2.3. Increasing women population 3.3. Global Contraceptive market Restraints: Impact Analysis 3.3.1. Increasing prevalence of side effects due to improper use of contraception products 3.4. Opportunities 3.4.1. Untapped market like developing countries and increasing medical tourism 3.5. Porters Five Forces Analysis 3.5.1. Bargaining Power Of Suppliers 3.5.2. Bargaining Power Of Buyers 3.5.3. Threat From New Entrants 3.5.4. Threat From New Substitutes 3.5.5. Degree Of Competition 3.6. Market Attractiveness Analysis 3.6.1. Market Attractiveness Analysis, by method type segment Chapter 4. Global Contraceptive Market Competitive Landscape 4.1. Company Market Share, 2014 (Subject To Data Availability) 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Source Launch 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures 4.2.4. Research And Development, Technology And Regional Expansion 4.3. Technology Portfolio 4.4. Patent Analysis (2011-2016) 4.4.1. Patent Trend 4.4.2. Patent Share By Company 4.4.3. By Region Chapter 5. Global Contraceptive Market Method type Analysis 5.1. Global Contraceptive market: Method type Segment Overview 5.1.1. Global Contraceptive market Revenue Share, By Method type Segment, 2015 And 2021 5.2. Contraceptive pills 5.2.1. Global Contraceptive market for contraceptive pills, 2015-2021 (USD Billion) 5.3. Injectables 5.3.1. Global Contraceptive market for Injectables, 2015-2021 (USD Billion) 5.4. Female sterilization 5.4.1. Global Contraceptive market for female sterilization, 2015-2021 (USD Billion) 5.5. Intrauterine devices systems 5.5.1. Global Contraceptive market for intrauterine devices systems, 2015-2021 (USD Billion) 5.6. Male condom 5.6.1. Global Contraceptive market for male condom, 2015-2021 (USD Billion) 5.7. Emergency contraception 5.7.1. Global Contraceptive market for Other, 2015-2021 (USD Billion) 5.8. Others 5.8.1. Global Contraceptive market for emergency contraception, 2015-2021 (USD Billion) Chapter 6. Global Contraceptive market Regional Segment Analysis 6.1. Global Contraceptive market: Regional Overview 6.1.1. Global Contraceptive market Revenue Share, By Region, 2014 And 2020 6.2. North America 6.2.1. North America Contraceptive market Revenue, by method type, 2015-2021 , (USD Billion) 6.3. Europe 6.3.1. Europe Contraceptive market Revenue, by method type, 2015-2021 , (USD Billion) 6.4. Asia Pacific 6.4.1. Asia Pacific Contraceptive market Revenue, by method type classification, 2015-2021 , (USD Billion) 6.5. Latin America 6.5.1. Latin America Contraceptive market Revenue, by method type, 2015-2021 , (USD Billion) 6.6. Middle East and Africa 6.6.1. Middle East and Africa Contraceptive market Revenue, by method type, 2015-2021 , (USD Billion) Chapter 7. Company Profile 7.1. The Female Health Company 7.1.1. Overview 7.1.2. Financials 7.1.3. Technology Portfolio 7.1.4. Business Strategy 7.1.5. Recent Developments 7.2. Teva Pharmaceutical Industries 7.2.1. Overview 7.2.2. Financials 7.2.3. Technology Portfolio 7.2.4. Business Strategy 7.2.5. Recent Developments 7.3. Bayer Healthcare Pharmaceuticals 7.3.1. Overview 7.3.2. Financials 7.3.3. Technology Portfolio 7.3.4. Business Strategy 7.3.5. Recent Developments 7.4. Piramal Healthcare Limited 7.4.1. Overview 7.4.2. Financials 7.4.3. Technology Portfolio 7.4.4. Business Strategy 7.4.5. Recent Developments 7.5. Reckitt Benckiser Plc. 7.5.1. Financials 7.5.2. Technology Portfolio 7.5.3. Business Strategy 7.5.4. Recent Developments 7.6. Cipla Limited 7.6.1. Financials 7.6.2. Technology Portfolio 7.6.3. Business Strategy 7.6.4. Recent Developments 7.7. Novartis AG 7.7.1. Overview 7.7.2. Financials 7.7.3. Technology Portfolio 7.7.4. Business Strategy 7.7.5. Recent Developments 7.8. Lupin Pharmaceuticals, Inc, 7.8.1. Overview 7.8.2. Financials 7.8.3. Technology Portfolio 7.8.4. Business Strategy 7.8.5. Recent Developments 7.9. Pfizer, Inc. 7.9.1. Overview 7.9.2. Financials 7.9.3. Technology Portfolio 7.9.4. Business Strategy 7.9.5. Recent Developments 7.10. Amgen Inc. 7.10.1. Overview 7.10.2. Financials 7.10.3. Technology Portfolio 7.10.4. Business Strategy 7.10.5. Recent Developments 7.11. Sun Pharmaceutical Industries Ltd. 7.11.1. Overview 7.11.2. Financials 7.11.3. Technology Portfolio 7.11.4. Business Strategy 7.11.5. Recent Developments 7.12. Glenmark Pharmaceuticals 7.12.1. Overview 7.12.2. Financials 7.12.3. Technology Portfolio 7.12.4. Business Strategy 7.12.5. Recent Developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to